Official Journal of Research Center for Gastroenterology and Liver Diseases
CrossRef
Works that cite this article, indexed by Crossref.
Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial
EBioMedicine 21 (2017)
Mostafa Yakoot; Alaa M. Abdo; Siham Abdel-Rehim; Sherine Helmy
SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial
Clinical Infectious Diseases 70(10) (2020)
Shahin Merat; Shahin Merat; Amir-Houshang Sharifi; Hossein Poustchi; Eskandar Hajiani; Abdolsamad Gharavi; Jalal Karimi; Fariborz Mansour-Ghanaei; Mohammad-Reza Fattahi; Lida Ahmadi; Mohammad-Hossein Somi; Hamid Kalantari; Mohammad-Reza Ghadir; Farshad Sheikhesmaeili; Nadieh Baniasadi; Masoudreza Sohrabi; Seyedhamid Moosavy; Masood Ziaee; Mohammad-Javad Zahedi; Marjan Mokhtare; Shahnaz Sali; Babak Sayad; Behrooz Afshar; Alireza Bakhshipour; Abazar Parsi; Afsaneh Sharifian; Taghi Amiriani; Zeinab Malekzadeh; Dorsa Merat; Azita Ganji; Fereidoun Rahmani-Samani; Raika Jamali; Masoomeh Sofian; Mohammad Ghezlou; Amir Ali Sohrabpour; Ladan Goshayeshi; Seyed-Mohammad Valizadeh-Toosi; Layli Eslami; Iradj Maleki; Ahmad Hormati; Ali-Akbar Shayesteh; Elahe Shayesteh; Alireza Norouzi; Zahra Abna; Alireza Janbakhsh; Hafez Fakheri; Mohammad Minakari; Hossein Sardarian; Adel Fallah Ghajary; Mojtaba Fattahi-Abdizadeh; Maryam Latifnia; Fatemeh Roozbeh; Shahram Agah; Saba Fakhrieh-Asl; Alireza Nateghi-Baygi; Babak Fattahi; Helia Nateghi-Baygi; Andrew Hill; Reza Malekzadeh
Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin
European Journal of Chemistry 10(4) (2019)
Maha Mahmoud Abou El-Alamin; Maha Abd Elrahman Sultan; Maha Hegazy; Alastair William Wark; Marwa Mohamed Azab
Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis
Hepatitis Monthly 17(6) (2017)
Mohammad Saeid Rezaee-Zavareh; Khashayar Hesamizadeh; Heidar Sharafi; Seyed Moayed Alavian
Research progress on the direct antiviral drugs for hepatitis C virus
BioScience Trends 11(1) (2017)
Jianjun Gao; Chuanxia Ju
Two New Naphthoquinone‐Naphthalene Hybrid Dimers From a Marine‐Derived Streptomyces Species
Chemistry & Biodiversity 23(3) (2026)
Shupeng Yin; Yuping Chi; Liman Zhou; Weiming Zhu; Peng Fu
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam
Journal of Viral Hepatitis 32(11) (2025)
Didier Laureillard; Nguyen Thanh Binh; Vu Hai Vinh; Tran Thi Hong; Catherine Quillet; Nham Thi Tuyet Thanh; Roselyne Vallo; Bach Thi Nhu Quynh; Jean Pierre Moles; Khuat Thi Hai Oanh; Duong Thi Huong; Delphine Rapoud; Jonathan Feelemyer; Laurent Michel; Peter Vickerman; Hannah Fraser; Laurence Weiss; Maud Lemoine; Karine Lacombe; Don Des Jarlais; Pham Minh Khue; Nicolas Nagot
Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’
European Journal of Gastroenterology & Hepatology 30(7) (2018)
Seyed M. Alavian; Heidar Sharafi
Efficacy and safety of anti-Hepatitis C virus regimens containing daclatasvir: a systematic review and meta-analysis from Egypt
Egyptian Liver Journal 15(1) (2025)
Muhammad Abdel-Gawad; Amro M. Hassan; Ahmed Q. Mohammed; Ashraf M. Al Kabeer; Eman Marwan; Mohamed M. Abd Elnaser; Mohamed El-Kassas
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
Annals of Hepatology 16(2) (2017)
Mohammad Saeid Rezaee-Zavareh; Khashayar Hesamizadeh; Bita Behnava; Seyed Moayed Alavian; Mohammad Gholami-Fesharaki; Heidar Sharafi
Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia
Journal of Medical Virology 91(3) (2019)
Arezoo Khosravi; Hamidreza Karimi‐Sari; Mahdi Abedi‐Andani; Bita Behnava; Ali Namvar; Ali Anvar; Seyed Moayed Alavian
Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation
Alimentary Pharmacology & Therapeutics 46(1) (2017)
M. S. Rezaee‐Zavareh; S. M. Alavian
Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017
Hepatitis Monthly 17(11) (2017)
Seyed Moayed Alavian; Heidar Sharafi
The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3
Hepatitis Monthly 17(1) (2016)
Shahin Merat; Amir Houshang Sharifi; Arghavan Haj-Sheykholeslami; Hossein Poustchi; Babak Fattahi; Alireza Nateghi-Baygi; Seyed Moayed Alavian; Reza Malekzadeh
Highly sensitive and selective β-Ni(OH)2@CNTs modified electrode for detection of Anti-Hepatitis C
Microchemical Journal 215 (2025)
Melad Lotfallah Adolf; Mahmoud A. Hefnawy; Shymaa S. Medany; Eman Yossri Frag